WASHINGTON — A little-known nonprofit established by Congress over 10 years ago to help the Food and Drug Administration work with the private sector is still struggling with a basic question: Where is the cash?

The Reagan-Udall Foundation for the FDA is supposed to act as a liaison between the FDA itself and drug companies, researchers, nonprofits, or other businesses with regulated products who might want to support a project to make the agency’s job easier. It has raised just under $15 million during its first decade, according to the foundation.

Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Well, we saw how these foundations work recently with the NIAAA study to prove alcohol is healthy or at least harmless – enabled by “foundation” money from the liquor lobby. These foundations are no different than PACs (Pharmaceutical Action Committees) where Big Pharma can launder the money to enable studies the government really does not hold in high priority, but that will jump-start sales for some special interest. The researchers and CDC/NIH/FDA can claim no conflict of interest (wink-wink, nudge-nudge); and some university gets a big grant with industry money nicely hidden in plain sight. How could that be a problem?

    • Exactly!
      Foundations like PhRMA get what they pay for. They even “educate” journalists, a clever way to promote the industry while suppressing questions. The Industry trolls have not shown up yet. They tend to overwhelm these sections with glowing endorsements of these foundations or the industry that is no longer accountable.

  • This foundation is pretty irrelevant now. There are plenty of industry insiders “helping” the FDA. These corporations prefer to track their drugs safety in house, so they can deny any problems ever occurred. That way is a lot more profitable, and the information stays proprietary. Every body wins, except for the people taking these over-hyped drugs, and of course the taxpayers that pay for them through Medicare. Even Medicare is not allowed to track any of this, pharma lobbyists told congress that was “Government Overreach.” One fourth of the deaths attributed to opioid overdoses were actually other pharmaceuticals, yet these deaths are not considered a problem for pharma. It was really clever how they got these deaths re-categorized. The same with Adverse Events, reporting those common occurrences is a waste of time, since the FDA ignored the reports on Fentanyl, back in 2008.
    Brain damage, hospital admissions, and death are being deliberately misreported, or unreported, thanks to the criminals at pharma.

Your daily dose of news in health and medicine

Privacy Policy